Update on the Implementation of Measles 2 nd Dose in India Ms. Anuradha Gupta Joint Secretary, Ministry of Health Govt. of India Global Measles and Rubella.

Slides:



Advertisements
Similar presentations
Measles / MMR Vaccine Developments last 6 months Dr.Sanjay Srirampur 1/16/20141IAPCOI Measles/MMR - Dec 2011.
Advertisements

Global Measles and Rubella Strategic Plan
1 June 2011 Measles update- India Dr. Satish Kumar Gupta Health Specialist UNICEF- India 13 th September 2011.
Immunization Services DR. KANUPRIYA CHATURVEDI DR.S.K. CHATURVEDI.
1 Dr. Azhar Abid Raza Washington Sept 2011 Measles elimination in Pakistan.
NPSP – Structure and Function
Pentavalent vaccine Introduction in UIP in India:
The Cape Verde experience with rubella outbreak & lessons from introducing rubella vaccines MoH Cape Verde ARCI meeting Dar es Salaam, Tanzania Dec 2012.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
Strengthening Routine Infant Immunization in EMR Partners for Measles Advocacy February, 2007 Eastern Mediterranean Regional Office Vaccines Preventable.
Proceedings of the SAGE Working Group on Rubella Vaccines Susan E. Reef, MD Global Measles and Rubella Management Meeting March 15, 2011.
Supporting Routine AND Supplementary Immunization Activities in STOP.
National Mental Health Programme. Govt of India integrated mental health with other health services at rural level. It is being implemented since 1982.
21 st May pm WHO conference room Expanded Program on Immunization.
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
Routine Immunization: The Missed Child Perspective Maya van den Ent, PharmD MPH Edward Hoekstra, MD, MSc David Brown, DSc, MScPH, MSc Halima Dao, MD, MSc.
National Rural Health Mission: A revolution in the health sector Subodh S Gupta Dr. Sushila Nayar School of Public Health MGIMS, Sewagram.
RNTCP: DOTS Expansion and plans for DOTS-Plus
DR. S.K CHATURVEDI UNICEF HIV/AIDS PREVENTION PROGRAMME PROGRAMME PLAN OF COOPERATION
1 AFRO Measles TAG – Nairobi 2-3 June 2015 MCV2 Introduction and the Second Year of Life Contact Lessons and way forward Raoul KAMADJEU UNICEF ESARO Meeting.
A Comprehensive Policy framework for the National Immunization Programme Dr Nihal Abeysinghe, [M.B.,B.S., MSc, M.D.] Chief Epidemiologist, Ministry of.
Polio eradication programme in India – Progress, Response and Issues for action Dr Ajay Khera Deputy Commissioner Ministry of Health & FW, Govt. of India.
Routine Immunization: R ecent initiatives and progress in high risk areas 23 rd India Expert Advisory Group July, 2011 Dr Pradeep Haldar, MoHFW,
Improving Health System and Strengthening NRHM through Community Action Experiences, Lessons Learnt, Challenges and Way Forward AGCA Secretariat Population.
Conclusions & Recommendations 24 th IEAG March 2012.
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
Measles Initiative Financing February 28, 2007 Washington, D.C. Andrea Gay UN Foundation for Measles Partners.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) September,
A Call To Action: Supporting India’s Commitment to the Global Strategy for Women and Children’s Health Maternal and Child Health Integrated Program (MCHIP)
Immunization service delivery – immunization management prospective.
Role of Schools - in Implementation of Measles catch-up campaigns
IMMUNIZATION IN UGANDA Dan Wamanya IMMUNIZATION IN UGANDA Dan Wamanya USAID/Uganda.
Microplanning for Routine Immunization
Accelerating Child Survival and Development in Gujarat and in India Dr Genevieve Begkoyian, MD MPH Chief of Health, India Country Office Healthy Gujarat.
Polio Eradication  Although the number of endemic countries is at an all-time low in 2002, the actual number of cases was approximately four times higher.
Edward J. Hoekstra, MD, MSc Edward J. Hoekstra, MD, MSc Senior Health Advisor Senior Health Advisor UNICEF HQ, New York UNICEF HQ, New York Peter Strebel,
MEASLES MORTALITY REDUCTION IN INDIA Status and Future Plans.
Update on Measles Mortality Reduction Activities and Linkages with RI.
Progress of Polio Eradication in India, Current Risks & Actions taken on last IEAG report 24 th IEAG, New Delhi 15 March 2012 Dr. Ajay Khera Deputy Commissioner.
14 th Measles and Rubella Initiative Meeting Mona Aryal HOD, Health Service Department Nepal Red Cross Society National Headquarter Nepal Red Cross Society’s.
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
Initiatives to improve UIP including convergence with polio activities Dr. Pradeep Haldar 24 th Meeting of IEAG March, 2012.
Global Strategy On Infant and Young Child Feeding State of Implementation in the context of MDG4 Country – India South Asia Breastfeeding Partners Forum.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
Strengthening Village Health and Nutrition Days: Key strategies and lessons learned from Uttar Pradesh, India Presenter: Ashok Kumar Singh Senior Technical.
MEASLES AND RUBELLA INITIATIVE Presentation by : Sylvia Khamati. Health Advisor Kenya Red Cross Society “Story from the Field” 15 th September 2015 American.
AGENDA AGENDA Twenty -Third Meeting of the India Expert Advisory Group (IEAG) for Polio Eradication July 2011, Hotel Taj Mahal, Mansingh Road, New.
WHO Regional Office for Europe Update on WHO GAVI European Regional Working Group and hepatitis B Immunization Viral Hepatitis Prevention Board Meeting.
Global Overview of Measles & Rubella 11 th Annual Meeting The Measles Initiative Washington, DC th September, 2012.
APPLYING LESSONS LEARNED TO FOLLOW-UP CAMPAIGNS, NIGERIA
1 |1 | Measles pre-elimination and resurgence in the African region Balcha Masresha IVD AFRO Global Measles Management Meeting Geneva March 2011.
India: Transitioning of Polio Network to Support Other Immunization Activities Jeffrey W McFarland, MD Regional Advisor, WHO South-East Asia Regional Office.
Supplementary Immunization Activities Quality, Coverage of high risk populations/ areas, proposed plans for IEAG Meeting 15 March 2011.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
Poliovirus Surveillance status of quality, actions to improve sensitivity WHO-India 15 March 2012.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
12 th Annual Meeting of The Measles & Rubella Initiative American Red Cross, Washington, DC September, 2013.
New Vaccine Introduction ‘MR vaccine introduction in Kenya’
World Health Organization Western Pacific Regional Office Expanded Programme on Immunization Measles Elimination in the Western Pacific Region 2007 Partners.
Micro-planning to ensure Supplementary Immunization Activity (SIA) reaches the unvaccinated- India Experience Dr Pradeep Haldar, DC(I), Government of India.
Global Measles and Rubella: Highlights, Priorities and Critical Issues
Global Overview of Measles
Regional Consultation, New Delhi February 10, 2016
Module 8 CD-JEV immunization campaigns
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
Maintaining Elimination in an Environment of Persistent Importation
Dte. National Vector Borne Diseases Control Programme (NVBDCP), MOHFW
STRATEGIES AND PROGRESS
Presentation transcript:

Update on the Implementation of Measles 2 nd Dose in India Ms. Anuradha Gupta Joint Secretary, Ministry of Health Govt. of India Global Measles and Rubella Management Meeting Salle B, WHO Headquarters, Geneva, Switzerland March, 2011

Presentation outline  Context  Introducing 2 nd dose of measles vaccine in India -MCV2 – Routine immunization -MCV2 – Catch-up campaigns  Road map and way forward

India Context  India steps up public investment in health  National Rural Health Mission (NRHM) provides augmented funding to states to the tune of over INR 550 billion (>$12 billion) during  System strengthening -HR Augmentation: 2 nd ANM*, ASHAs #, additional doctors -Infrastructure, Ambulance networks -Communitization -Flexible financing * ANM: Auxiliary Nurse Midwife # ASHA: Accredited Social Health Activist

Global Context: Worldwide measles vaccination delivery strategies, mid-2010 MCV1 & MCV2, no SIAs (40 member states or 21%) MCV1 & regular SIAs (59 member states or 31%) MCV1, MCV2 & one-time catch-up (36 member states or 19%) MCV1, MCV2 & regular SIAs (57 member states or 28%) Single dose (1 member state or 1%) Data source: WHO/IVB measles database as of 26 January 2010 India national immunization programme introduced second dose of measles in 2010

Recommendations from expert Indian committees  National Technical Advisory Group on Immunization (NTAGI) recommended: 1.States with MCV1 coverage <80%: Second opportunity for measles vaccine through measles catch-up campaigns in 9 months - 10 years age 2.States with MCV1 coverage >80% MCV2 through routine immunization at months of age  Ad hoc expert review committee reviewed above strategy in early 2010 and endorsed the NTAGI recommendation

MCV2 introduction: State-specific delivery strategies  SIA in 14 states: -Target population (9 mo-10 years): 134 million -Vaccine doses and AD syringes: 147 million -Mixing syringe : 29.5 million  MCV2 in routine immunization in 21 states: -Annual targets 1-2 year population: ~10 million Vaccine doses: ~12 million RI: MCV1 > 80%: 21 states SIA: MCV1 <80%: 14 states

Introduction of 2 nd dose of Measles in RI, India Annual Target 1-2 year Ongoing: 4 states (0.4 million) 2010: 3 states (1.2 million) 2011: 11 states (5.9 million) To be decided: 3 states (2.2 mln)

Measles Catch-up campaigns

MCV2 introduction through catch-up vaccination campaign (MCUP) Phase 1  In three phases -Target: 134 million in 351 districts  Phase 1: -45 districts from 13 states with ~13 million target children 9 district from Chhattisgarh 5 districts from each of the 6 states (Bihar, Jharkhand, Rajasthan, Madhya Pradesh, Gujarat & Haryana) 1 district from each of the North-East states  Phase 2 to take place from September 2011  Phase 3 in 2012

Key operational strategies: MCUP-1  Immunization from fixed posts to ensure safe injection practices -Routine immunization and outreach sites used -Additional sites added as needed -Schools with children under 10 years targeted -Specific plans for hard to reach areas and/or underserved populations  Average campaign duration: 3 weeks = 12 working days -1st week: School based campaign (for 5-10 year children) -2nd & 3rd weeks: Community based campaign for remaining children  Medical officers trained to establish AEFI management networks equipped with management kits  Regular weekly RI sessions continued without interruption -Measles catch-up campaign activities conducted during remaining days of week

Measles catch-up campaign budget 1.Vaccine/ADS, 33.2 million USD 2.Op cost 25.9 million USD 3.Total 59.1 million USD  Target 134 million  Per child cost 0.44 USD

State (No. of Districts covered in phase 1) Administrative coverage achieved in 10.2 million children vaccinated so far (92% coverage) in 39 districts across 11 states * Provisional From 39 districts where campaign completed

Reasons for non-vaccination in MCUP1 (from Monitoring data)* Source: MoHFW, RCA monitoring Comm unicati on related Operat ional * As reported by caregivers to monitors

Experiences from Phase 1 catch-up campaigns  GoI supported all logistic and operation costs of the activities -Budget committed for subsequent phases  Cold chain capacity and management met expectations  No major issues with vaccine and injection equipment management  Large scale campaigns with injectable vaccines can be conducted safely in India -Medical officers in all SIA districts trained in AEFI management, reporting -No instance of AEFI due to programme error detected -All reported AEFIs managed effectively  Administrative coverage variable across states: -39 districts completed campaigns so far -49% (19/39) with >= 90% coverage

Areas for improvement  Coordination and planning -Better coordination among the three primary departments of Health, Education and ICDS -Flexible approach with states for timeline; but stringent adherence to agreed upon timeline  Communication and advocacy -IEC and interpersonal communication at grass-root level -Civil society and professional bodies: Indian Academy of Pediatrics, Indian Medical Association, Others -Private schools  Vaccination in urban areas poses special challenges  Injection waste management needs strengthening  Supervision needs to be improved at all levels.

Way forward  MCV2 introduction -Routine Immunization (21 states): Started in 7 states; will start in all 21 by Catch-up: Will complete in all 14 states by 2012 State and national review meetings to compile best practices and lessons learned planned in April 2011  Measles mortality reduction through immunization plus NRHM initiatives to improve access to health care at grassroots  Laboratory supported measles surveillance initially in states with higher burden -At least one state level laboratory in each state for measles serology  Build synergies of catch-up campaigns with Routine Immunization

Haryana: 22 Nov 2010 Rajasthan: 29 Nov 2010 Gujarat: 8 March 2011 Chhattisgarh: Dec 2010 Madhya Pradesh: 6 Dec 2010 Bihar: 13 Dec 2010 Assam, Arunachel Pradesh: 8 Nov 2010 Phase 1 calendar of catch-up campaigns Jharkhand: 31 Jan 2011 Nagaland 7 Feb 2011 Uttar Pradesh: ??? Manipur: 29 Nov 2010 Tripura 31 Jan 2011 Meghalaya 7 March 2011